NO995389L - COX-2-selektiv carprofen for behandling av smerte og betennelse i hunder - Google Patents

COX-2-selektiv carprofen for behandling av smerte og betennelse i hunder

Info

Publication number
NO995389L
NO995389L NO995389A NO995389A NO995389L NO 995389 L NO995389 L NO 995389L NO 995389 A NO995389 A NO 995389A NO 995389 A NO995389 A NO 995389A NO 995389 L NO995389 L NO 995389L
Authority
NO
Norway
Prior art keywords
carprofen
cox
dogs
inflammation
pain
Prior art date
Application number
NO995389A
Other languages
English (en)
Other versions
NO995389D0 (no
Inventor
Kristin Marie Lundby
Anthony Paul Ricketts
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO995389D0 publication Critical patent/NO995389D0/no
Publication of NO995389L publication Critical patent/NO995389L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
NO995389A 1997-05-05 1999-11-04 COX-2-selektiv carprofen for behandling av smerte og betennelse i hunder NO995389L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05
PCT/IB1998/000662 WO1998050033A1 (en) 1997-05-05 1998-05-01 Cox-2 selective carprofen for treating pain and inflammation in dogs

Publications (2)

Publication Number Publication Date
NO995389D0 NO995389D0 (no) 1999-11-04
NO995389L true NO995389L (no) 2000-01-04

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995389A NO995389L (no) 1997-05-05 1999-11-04 COX-2-selektiv carprofen for behandling av smerte og betennelse i hunder

Country Status (32)

Country Link
EP (1) EP0988034A1 (no)
JP (1) JP2000513020A (no)
KR (2) KR20040004406A (no)
CN (1) CN1255059A (no)
AP (1) AP9801234A0 (no)
AR (2) AR011726A1 (no)
AU (1) AU6932198A (no)
BG (1) BG103852A (no)
BR (1) BR9808720A (no)
CA (1) CA2288759A1 (no)
DZ (1) DZ2479A1 (no)
EA (1) EA003696B1 (no)
GT (1) GT199800063A (no)
HR (1) HRP980244A2 (no)
HU (1) HUP0001286A3 (no)
ID (1) ID21311A (no)
IL (1) IL132570A0 (no)
IS (1) IS5220A (no)
MA (1) MA26491A1 (no)
NO (1) NO995389L (no)
NZ (1) NZ500183A (no)
OA (1) OA11213A (no)
PA (1) PA8450601A1 (no)
PE (1) PE72599A1 (no)
PL (1) PL337003A1 (no)
SK (1) SK148199A3 (no)
TN (1) TNSN98059A1 (no)
TW (1) TW590773B (no)
UY (1) UY24989A1 (no)
WO (1) WO1998050033A1 (no)
YU (1) YU55899A (no)
ZA (1) ZA983722B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en) 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
CA2347365A1 (en) * 1998-10-23 2000-05-04 Merck Frosst Canada & Co. Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
NZ513965A (en) * 1999-03-10 2004-04-30 G Method and composition for administering a cyclooxygenase-2 inhibitor
AU1592901A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
US20020016342A1 (en) * 2000-05-15 2002-02-07 Edward Scolnick Combination therapy using COX-2 selective inhibitor and thromboxane inhibitor and compositions therefor
EA011309B1 (ru) 2000-06-13 2009-02-27 Вайет Составы для ослабления боли, содержащие целекоксиб
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
AU8475301A (en) 2000-08-07 2002-02-18 Univ Vanderbilt Detection of cox-2 activity and anandamide metabolites
WO2003007875A2 (en) * 2001-07-16 2003-01-30 Hoegestaett Edward Compounds with analgesic, antipyretic and/or anti-inflammatory activity
ES2275218T3 (es) 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
CA2533101A1 (en) * 2003-07-31 2005-02-03 Pharmacia & Upjohn Company Llc Dispersible formulation of an anti-inflammatory agent
EP1940380A2 (en) * 2005-05-20 2008-07-09 Pfizer Limited Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-2 delta-ligands
EP2061440A2 (en) * 2007-04-04 2009-05-27 Sigmoid Pharma Limited A pharmaceutical composition of tacrolimus
ES2963291T3 (es) 2007-04-26 2024-03-26 Sublimity Therapeutics Ltd Fabricación de múltiples minicápsulas
ES2530049T3 (es) 2009-05-18 2015-02-26 Sigmoid Pharma Limited Composición que comprende gotas de aceite
BR112012002963A2 (pt) 2009-08-12 2017-10-24 Sigmoid Pharma Ltd composições imunomoduladoras compreendendo uma matriz de polímero e uma fase oleosa
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
US12109218B2 (en) 2014-12-09 2024-10-08 Aratana Therapeutics, Inc. Compositions of grapiprant and methods for using the same
CN105939713A (zh) * 2014-03-06 2016-09-14 阿莱塔纳治疗学股份有限公司 格拉匹纶组合物及其使用方法
EA036036B1 (ru) 2014-11-07 2020-09-16 Сигмойд Фарма Лимитед Композиции, содержащие циклоспорин
WO2016112312A1 (en) * 2015-01-09 2016-07-14 Jaguar Animal Health Methods of treating diarrhea in companion animals
JP2023520367A (ja) * 2020-03-25 2023-05-17 エスアールアイ インターナショナル リポキシゲナーゼ阻害剤
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions

Also Published As

Publication number Publication date
AU6932198A (en) 1998-11-27
IL132570A0 (en) 2001-03-19
PE72599A1 (es) 1999-08-12
HUP0001286A3 (en) 2000-12-28
BG103852A (en) 2000-06-30
HRP980244A2 (en) 1999-02-28
EA003696B1 (ru) 2003-08-28
WO1998050033A1 (en) 1998-11-12
JP2000513020A (ja) 2000-10-03
DZ2479A1 (fr) 2003-02-01
GT199800063A (es) 1999-10-26
EP0988034A1 (en) 2000-03-29
EA199900895A1 (ru) 2000-06-26
UY24989A1 (es) 2001-10-25
ID21311A (id) 1999-05-20
AR039628A2 (es) 2005-03-02
SK148199A3 (en) 2001-09-11
AR011726A1 (es) 2000-08-30
PL337003A1 (en) 2000-07-31
NZ500183A (en) 2002-04-26
TW590773B (en) 2004-06-11
MA26491A1 (fr) 2004-12-20
OA11213A (en) 2003-07-14
BR9808720A (pt) 2000-07-11
YU55899A (sh) 2003-08-29
NO995389D0 (no) 1999-11-04
AP9801234A0 (en) 1999-11-04
CA2288759A1 (en) 1998-11-12
KR20010012300A (ko) 2001-02-15
TNSN98059A1 (fr) 2005-03-15
HUP0001286A2 (hu) 2000-11-28
CN1255059A (zh) 2000-05-31
IS5220A (is) 1999-10-19
PA8450601A1 (es) 2000-05-24
KR20040004406A (ko) 2004-01-13
ZA983722B (en) 1999-11-04

Similar Documents

Publication Publication Date Title
NO995389D0 (no) COX-2-selektiv carprofen for behandling av smerte og betennelse i hunder
NO20005190L (no) Terapeutiske angiogene faktorer og fremgangsmåter til anvendelse derav
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
DE69825447D1 (de) Gerät zur dermatologischen behandlung
NO983576L (no) Br°nnbehandlingsfluider og fremgangsmÕter
IS5405A (is) Prostaglandín gerandefni og notkun þeirra til að meðhöndla beintruflanir
ID18741A (id) Zat nikotinat dalam terapi
DE69630947D1 (de) Mittel zur schmerzbehandlung
NO20022656D0 (no) Caspaseinhibitorer og anvendelse derav
EE05073B1 (et) Retigabiin kasutamiseks neuropaatilise valu ravis
EE200100480A (et) Ksenoon kasutamiseks närvimürgistuste ravis
EE9900421A (et) Koduse olmeheitvee puhastussüsteem ja meetod
NO980687D0 (no) System og fremgangsmåte for perfusjon-hypertermibehandling
DE60019490D1 (de) Brennstofförder-und behandlungsvorrichtung
NO20005179D0 (no) Medikament behandling
PT946175E (pt) Utilizacao de uma combinacao de inibidores de h+, k+ -atpase e de glucocorticiodes no tratamento de polipos nasais
DE69701250D1 (de) Tierbehandlungsvorrichtung
NO20012738D0 (no) Terapeutiske produkter og anvendelse derav
ID24060A (id) Pengolahan kulit hewan yang ditingkatkan
PL354484A1 (pl) Zastosowanie flupirtyny do łagodzenia bólu związanego z chorobami zwyrodnieniowymi stawów u psów i kotów
ITMI20001555A0 (it) Procedimento e dispositivo di trattamento elettrochimico
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
DE69932577D1 (de) Stangenbehandlungsgerät und Stangenladegerät
FI974353L (fi) Suoraan ihovarastona käytettävä liuos käytettäväksi loisia vastaan nautakarjalla ja lampailla
DK0915655T3 (da) Fremgangsmåde og sammensætning til behandling mod parasitter i dyrs omgivelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application